Medicago's coronavirus vaccine projects backed by Canadian govt

TORONTO (Reuters) - Quebec's Medicago, owned by Mitsubishi Tanabe Pharma and Philip Morris, said on Thursday its experimental COVID-19 vaccine, developed with limited government funding, would go into late-stage trials before the end of the year, cementing its lead in the race for a Canadian-made vaccine.

The following is a roundup of other coronavirus vaccine projects in Canada that have also won federal support.   * In May, Canada's National Research Council (NRC) said it would collaborate with CanSino Biologics,.....

This article is no longer available in our repository.

There could be multiple reasons for this.